Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

major pharmaceuticals - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - potassium chloride oral solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. potassium chloride is contraindicated in patients on potassium sparing diuretics. there are no human data related to use of potassium chloride during pregnancy, and animal studies have not been conducted. potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm. the background risk for major birth defects and miscarriage in the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary the normal potassium ion content of human milk is about 13 meq per liter. since potassium from oral supp

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

major pharmaceuticals - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder (mdd). efficacy was established in three short-term (4, 8, and 12 weeks) and two long-term, maintenance trials. venlafaxine hydrochloride extended-release capsules are indicated for the treatment of generalized anxiety disorder (gad). efficacy was established in two 8-week and two 26-week placebo-controlled trials. venlafaxine hydrochloride extended-release capsules, usp are indicated for the treatment of social anxiety disorder (sad), also known as social phobia. efficacy was established in four 12-week and one 26-week, placebo-controlled trials. venlafaxine hydrochloride extended-release capsules are indicated for the treatment of panic disorder (pd), with or without agoraphobia. efficacy was established in two 12-week placebo-controlled trials. hypersensitivity to venlafaxine hydrochloride, desvenlafaxine succinate or to any excipients in the formulation the use of maois (intended to treat psych

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

major pharmaceuticals - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - tramadol hydrochloride tablets are indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1)] , reserve tramadol hydrochloride for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: tramadol hydrochloride tablets are contraindicated for: tramadol hydrochloride tablets are also contraindicated in patients with: risk summary prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with tramadol hydrochloride in pregnant women are insufficient to inform a drug- associated risk for major birth defects and miscarriage. in animal reproduction studies, tramadol administration during organogenesis decreased fetal weights and reduced ossification in mice, rats, and rabbits at 1.4, 0.6, and 3.6 tim

Kuba - ispanų - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

major pharmaceuticals. - simeticona - suspensión oral - 66,6 mg/ml

Kuba - ispanų - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

major pharmaceuticals. - vitamina a (como acetato); vitamina c (como ácido ascórbico); vitamina d3 (como colecalciferol); vitamina b1 (como clorhidrato de tiamina); vitamina b2 (riboflavina); niacinamida (como vitamina b3); vitamina b6 (como clorhidrato de piridoxina); Ácido fólico; vitamina b12 (como cianocobalamina) - tableta - 5 000 ui; 60 mg; 400 ui; 1,5 mg; 1,7 mg; 20 mg; 2 mg; 0,4 mg; 6 mcg

Kuba - ispanų - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

major pharmaceuticals. - calcio; vitamina d3 - tableta - 600 mg; 400 ui

Kuba - ispanų - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

major pharmaceuticals. - calcio; vitamina d3 - tableta - 600 mg; 400 ui

Kuba - ispanų - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

major pharmaceuticals. - vitamina a; vitamina c; vitamina d3; vitamina b1; vitamina b2; niacina b3; vitamina b6; Ácido fólico; vitamina b12; Ácido pantoténico; hierro - tableta - 5 000 ui; 50 mg; 400 ui; 2 mg; 2,5 mg; 20 mg; 1 mg; 400 mcg; 1 mcg; 1 mg; 15 mg

Kuba - ispanų - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

major pharmaceuticals. - vitamina a; vitamina c; vitamina d; vitamina e; vitamina k; vitamina b1; vitamina b2; niacinamida; vitamina b6; Ácido fólico; vitamina b12; biotina; Ácido pantoténico; calcio; hierro; yoduro; zinc; cobre; ascorbato de sodio - tableta masticable - 3000 ui; 60 mg; 600 ui; 30 ui; 55 mcg; 1,5 mg; 1,7 mg; 15 mg; 2 mg; 0,4 mg; 6 mcg; 40 mcg; 10 mg; 100 mg; 18 mg; 150 mcg; 12 mg; 2 mg; 21 mg

Kuba - ispanų - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

major pharmaceuticals. - subsalicilato de bismuto (total de salicilato 102 mg) - tableta masticable - 262 mg